Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry Disease
Background/Aims: Fabry disease (FD) is a rare inherited lysosomal storage disease with common and serious kidney complications. Enzyme replacement therapies (ERT) with agalsidase-α and -β were investigated to characterize their therapeutic effect on kidney function in FD patients with Classic phenot...
Main Authors: | Albina Nowak, Gilbert Koch, Uyen Huynh-Do, Martin Siegenthaler, Hans-Peter Marti, Marc Pfister |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-02-01
|
Series: | Kidney & Blood Pressure Research |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/464312 |
Similar Items
-
Two related Chinese Fabry disease patients with a p.N215S pathological variant who presented with nephropathy
by: Bun Sheng, et al.
Published: (2020-09-01) -
Kidney Transplant in Fabry Disease: A Revision of the Literature
by: Irene Capelli, et al.
Published: (2020-06-01) -
Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis
by: Taciane Alegra, et al.
Published: (2012-01-01) -
Effectiveness of enzyme replacement therapy in Fabry disease: Long term experience in Argentina
by: Gustavo Cabrera, et al.
Published: (2017-06-01) -
Improvement of gastrointestinal symptoms in a significant proportion of male patients with classic Fabry disease treated with agalsidase beta: A Fabry Registry analysis stratified by phenotype
by: Robert J. Hopkin, et al.
Published: (2020-12-01)